selected scholarly activity
-
academic article
- Partial nephrectomy in frail patients: Benefits of robot-assisted surgery. Surgical Oncology. 38:101588-101588. 2021
- Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study. Clinical Oncology Comparative Haematology International. 33:468-475. 2021
- Canadian consensus forum of key controversial areas in the management of advanced prostate cancer. Journal of the Canadian Urological Association. 15. 2021
- Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 39:371.e17-371.e25. 2021
- The increasing use of renal tumor biopsy amongst Canadian urologists: When is biopsy most utilized?. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 2021
- Achieving the “trifecta” with open versus minimally invasive partial nephrectomy. World Journal of Urology. 39:1569-1575. 2021
- Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System. Clinical Genitourinary Cancer. 2021
- Hypothermia During Partial Nephrectomy for Patients with Renal Tumors: A Randomized Controlled Trial. JOURNAL OF UROLOGY. 205:1303-1309. 2021
- The impact of sex and age on distribution of metastases in patients with renal cell carcinoma. International Journal of Clinical Oncology. 26:962-970. 2021
- Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma. New England Journal of Medicine. 384:1289-1300. 2021
- Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 39:239.e1-239.e7. 2021
- Development, implementation, and evaluation of a competency-based didactic and simulation-focused boot camp for incoming urology residents: Report of the first three years. Journal of the Canadian Urological Association. 15:98-105. 2021
- Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021. Journal of the Canadian Urological Association. 15:84-97. 2021
- Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system. Journal of the Canadian Urological Association. 15:132-137. 2021
- Real-Word Experience of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis). Kidney Cancer. 5:21-29. 2021
- Images – Rare diagnosis of high-grade, undifferentiated pelvic sarcoma for urinary dysfunction in a young man. Journal of the Canadian Urological Association. 15:E192-E194. 2021
- Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel towards Prostate Cancer Relapse. Genes. 12:257-257. 2021
- 2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC) (full-text). Journal of the Canadian Urological Association. 15:E81-9. 2021
- Comparison of a magnetic retrieval device vs. flexible cystoscopy for removal of ureteral stents in renal transplant patients: A randomized controlled trial. Journal of the Canadian Urological Association. 15:E97-E102. 2021
- Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1–4 cm renal cell carcinomas. Cancer Causes and Control. 32:119-126. 2021
- Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists. Journal of the Canadian Urological Association. 15:E90-E96. 2021
- Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific Validation. European Urology Focus. 2021
- Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network. Cancers. 13:430-430. 2021
- Evolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reports. PLoS ONE. 16:e0253876-e0253876. 2021
- Reply By Authors. JOURNAL OF UROLOGY. 205:84-85. 2021
- Utilization of Salvage and Systemic Therapies for Recurrent Prostate Cancer as a Result of 18F-DCFPyL PET/CT Restaging. Advances in Radiation Oncology. 6:100553-100553. 2021
- Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report. Current Oncology. 28:226-232. 2020
- Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 18:e730-e738. 2020
- Expert and Crowdsourced Evaluation of Image Quality From a Novel Endoscopy Phone Light Adapter. Urology. 146:54-58. 2020
- Management of complex renal cysts in Canada: results of a survey study. BMC Urology. 20:47. 2020
- Surveillance post-radiofrequency ablation for small renal masses: Recurrence and followup. Journal of the Canadian Urological Association. 14:398-403. 2020
- Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma. Cancers. 12:3471-3471. 2020
- Canadian Urological Association Best Practice Report: Diagnosis and management of sporadic angiomyolipomas. Journal of the Canadian Urological Association. 14:E527-E536. 2020
- Determining Generalizability of the Canadian Kidney Cancer information system (CKCis) to the Entire Canadian Kidney Cancer Population. Journal of the Canadian Urological Association. 14:E499-E506. 2020
- Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence?. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 38:798.e9-798.e16. 2020
- Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma. Clinical Genitourinary Cancer. 18:e610-e618. 2020
- Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 38:799.e1-799.e10. 2020
- Partial vs. radical nephrectomy and the risk of all-cause mortality, cardiovascular, and nephrological outcomes. Journal of the Canadian Urological Association. 14:337-345. 2020
- Renal Cell Carcinoma: Comparison between Variant Histology and Clear Cell Carcinoma across All Stages and Treatment Modalities. JOURNAL OF UROLOGY. 204:671-676. 2020
- Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines. Journal of the National Comprehensive Cancer Network : JNCCN. 18:1340-1347. 2020
- A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality. Clinical Genitourinary Cancer. 18:314-321.e1. 2020
- Acute care for renal colic in Canadian healthcare — a commentary on emergency department patient flow metrics and treatment options. Journal of the Canadian Urological Association. 14:265-266. 2020
- Evolving Role of Urologists in the Management of Advanced Renal Cell Carcinoma. Urologic Clinics of North America. 47:271-280. 2020
- Contactin 1: An Important and Emerging Oncogenic Protein Promoting Cancer Progression and Metastasis. Genes. 11:874-874. 2020
- Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 26:2327-2336. 2020
- A A Canadian consensus forum on the management of patients with advanced prostate cancer. Journal of the Canadian Urological Association. 14:E137-E149. 2020
- Immunohistochemistry Use by Diagnostic Category and Pathologist in 4477 Prostate Core Biopsy Sets Assessed at Two Hospitals. Applied Immunohistochemistry and Molecular Morphology Applied Immunohistochemistry. 28:259-266. 2020
- Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer. Journal of the Canadian Urological Association. 14:122-129. 2020
- The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert. Genes. 11:312-312. 2020
- A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. International Journal of Radiation Oncology Biology Physics. 106:546-555. 2020
- Preoperative frailty predicts adverse short‐term postoperative outcomes in patients treated with radical nephroureterectomy. Journal of Surgical Oncology Seminars in Surgical Oncology. 121:688-696. 2020
- Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database–based Study. European Urology Focus. 2020
- Contributions of DNA Damage to Alzheimer’s Disease. International Journal of Molecular Sciences. 21:1666-1666. 2020
- Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer. Journal of the Canadian Urological Association. 14:17-23. 2020
- Does Bone-targeted Therapy Benefit Patients with Metastatic Renal Cell Carcinoma?. Translational Oncology. 13:241-244. 2020
- Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database. Clinical Oncology Comparative Haematology International. 32:e10-e15. 2020
- Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases. Asian Journal of Andrology. 22:437-437. 2020
- The role and timing of cytoreductive nephrectomy in the immunotherapy era. European Urology Focus. 6:7-8. 2020
- Assessment of biochemical recurrence of prostate cancer (Review). International Journal of Oncology. 55:1194-1212. 2019
- Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer. Journal of the Canadian Urological Association. 13:404-405. 2019
- Reply by Authors. JOURNAL OF UROLOGY. 202:1274-1274. 2019
- Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019. Journal of the Canadian Urological Association. 13:343-54. 2019
- Morphologic subtyping as a prognostic predictor for survival in papillary renal cell carcinoma: Type 1 vs. type 2. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 37:721-726. 2019
- Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 37:576.e11-576.e16. 2019
- High‐grade oncocytic tumour (HOT) of kidney in a patient with tuberous sclerosis complex. Histopathology. 75:440-442. 2019
- Circulating microvesicle protein is associated with renal transplant outcome. Transplant Immunology. 55:101210-101210. 2019
- Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. JOURNAL OF UROLOGY. 202:282-289. 2019
- The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer. Cancers. 11:1028-1028. 2019
- Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma. Journal of Endourology. 33:606-613. 2019
- 2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC). Journal of the Canadian Urological Association. 13:307-314. 2019
- Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma. Journal of the Canadian Urological Association. 13:166-174. 2019
- Renal Cell Carcinoma in the Canadian Indigenous Population. Current Oncology. 26:367-371. 2019
- Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years. European Urology Focus. 5:467-473. 2019
- Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study. European Urology Focus. 5:488-496. 2019
- The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?. Future Oncology. 15:1683-1695. 2019
- The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis. Cancers. 11:434-434. 2019
- Upfront cytoreductive nephrectomy vs. upfront systemic therapy in metastatic kidney cancer. Journal of the Canadian Urological Association. 13:E377-E381. 2019
- Canadian Urological Association Best Practice Report: Diagnosis and management of radiation-induced hemorrhagic cystitis. Journal of the Canadian Urological Association. 13:15-23. 2019
- The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial. European Journal of Cancer. 108:69-77. 2019
- Canadian Urological Association guideline: Muscle-invasive bladder cancer. Journal of the Canadian Urological Association. 13:230-238. 2019
-
Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome
. Cancer Management and Research. Volume 11:9307-9319. 2019 - FAM84B promotes prostate tumorigenesis through a network alteration. Therapeutic Advances in Medical Oncology. 11:175883591984637-175883591984637. 2019
- Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol. BMJ Open. 9:e025662-e025662. 2019
- 18F-DCFPyL PET/CT in Oncocytoma. Clinical Nuclear Medicine. 43:921-924. 2018
- Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence. Clinical Drug Investigation. 38:1155-1165. 2018
- External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World Journal of Urology. 36:1973-1980. 2018
- SDH-deficient renal cell carcinoma – clinical, pathologic and genetic correlates: a case report. BMC Urology. 18:109. 2018
- Use of Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma: Clinical and Economic Impact in a Canadian Real-Life Setting. Current Oncology. 25:576-584. 2018
- Is There a Role for Adjuvant Therapy After Surgery in “High Risk for Recurrence” Kidney Cancer? an Update on Current Concepts. Current Oncology. 25:444-453. 2018
- Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma. Cancer Detection and Prevention Cancer Epidemiology. 56:118-125. 2018
- Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Cancer. 124:3677-3683. 2018
- Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidence. Journal of the Canadian Urological Association. 12:E415-20. 2018
- Thrombotic characteristics of extracellular vesicles derived from prostate cancer cells. Prostate. 78:953-961. 2018
- A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy. JOURNAL OF UROLOGY. 200:335-343. 2018
- Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development. Translational Oncology. 11:1012-1022. 2018
- Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma. Journal of the Canadian Urological Association. 12:231-238. 2018
- Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma. Journal of the Canadian Urological Association. 12:243-251. 2018
- The Effect of Institution Teaching Status on Perioperative Outcomes After Robotic Partial or Radical Nephrectomy. Journal of Endourology. 32:621-629. 2018
- The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis. Journal of the Canadian Urological Association. 12:E325-30. 2018
- Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature. Clinical Genitourinary Cancer. 16:176-183. 2018
- Anastomosing Hemangioma of the Kidney: Radiologic and Pathologic Distinctions of a Kidney Cancer Mimic. Current Oncology. 25:220-223. 2018
- Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma. Cancer Detection and Prevention Cancer Epidemiology. 54:112-118. 2018
- Evolution of the CUA guideline – Raising the bar!. Journal of the Canadian Urological Association. 12:151-151. 2018
- Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Journal of the Canadian Urological Association. 12:173-80. 2018
- The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection?. Journal of the Canadian Urological Association. 12:E276-80. 2018
- Renal cell carcinoma in renal allograft: Case series and review of literature. Urology Annals. 10:229-232. 2018
- The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy. BJU International. 121:383-392. 2018
- Prostate cancer screening among family physicians in Ontario: An update on attitudes and current practice. Journal of the Canadian Urological Association. 12:E53-8. 2018
- Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy. World Journal of Urology. 36:51-57. 2018
- Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study. CMAJ Open. 5:E834-E841. 2017
- Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor. Journal of Biological Chemistry. 292:21180-21192. 2017
- Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1–2 N0 M0 renal cell carcinoma. World Journal of Urology. 35:1899-1905. 2017
- Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era. International Urology and Nephrology. 49:2143-2149. 2017
- Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression. Neoplasia. 19:857-867. 2017
- Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017. Journal of the Canadian Urological Association. 11:310-320. 2017
- Corrigendum to “Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles” [Eur J Cancer 70 (2017) 62–74]. European Journal of Cancer. 83:335-335. 2017
- Current management of metastatic renal cell carcinoma: evolving new therapies. Current Opinion in Supportive and Palliative Care. 11:231-237. 2017
- Benchmarking quality for renal cancer surgery: Canadian Kidney Cancer information system (CKCis) perspective. Journal of the Canadian Urological Association. 11:232-7. 2017
- Highlights of genitourinary cancer research presented at ASCO 2017. Journal of the Canadian Urological Association. 11:S297-S297. 2017
- Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC—A Possible Path Forward. Kidney Cancer. 1:31-40. 2017
- A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma. Journal of Endourology. 31:645-650. 2017
- Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma. JAMA Oncology. 3:913-913. 2017
- Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative. Journal of the Canadian Urological Association. 11:182-182. 2017
- Update from the American Society of Clinical Oncology 2017 Genitourinary Cancers Symposium (ASCO-GU). Journal of the Canadian Urological Association. 11:159-159. 2017
- Epidemiology of prostate and kidney cancer in the Aboriginal population of Canada: A systematic review. Journal of the Canadian Urological Association. 11:222-222. 2017
- Safety, reliability and accuracy of small renal tumour biopsies: results from a multi-institution registry. BJU International. 119:543-549. 2017
- Upregulation of FAM84B during prostate cancer progression. Oncotarget. 8:19218-19235. 2017
- Erratum to “The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System” [Urol Oncol 34(11) (2016) 486.e1–486.e7]. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 35:124-124. 2017
- First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience. Journal of the Canadian Urological Association. 11:112-112. 2017
- Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers. Journal of the Canadian Urological Association. 11:138-138. 2017
- Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma. World Journal of Urology. 35:355-365. 2017
- Re: Kapoor et al.: Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML) (Urology 2016; 89:19-26) Reply. Urology. 100:255-255. 2017
- Reply by the Authors. Urology. 100:255-255. 2017
- Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies. PLoS ONE. 12:e0173358-e0173358. 2017
- Next generation quality: Assessing the physician in clinical history completeness and diagnostic interpretations using funnel plots and normalized deviations plots in 3,854 prostate biopsies. Journal of Pathology Informatics. 8:43-43. 2017
- Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles. European Journal of Cancer. 70:62-74. 2017
- Amplification of MUC1 in prostate cancer metastasis and CRPC development. Oncotarget. 7:83115-83133. 2016
- Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cohrane Library Clinical Respiratory Journal. 12:CD010098. 2016
- Kidney cancer, ESMO 2016. Journal of the Canadian Urological Association. 10:S227-S230. 2016
- Sunitinib: 10 years of clinical experience in the treatment of advanced renal cell carcinoma. Journal of the Canadian Urological Association. 10:235-235. 2016
- Update on Bladder, Kidney, and Prostate Cancer from the European Society for Medical Oncology (ESMO) Annual Meeting 2016. Journal of the Canadian Urological Association. 10:223-223. 2016
- Contemporary agents in the management of metastatic castration-resistant prostate cancer. Journal of the Canadian Urological Association. 10:414-414. 2016
- Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 34:486.e17-486.e23. 2016
- First-line treatment options in metastatic renal cell cancer. Journal of the Canadian Urological Association. 10:236-236. 2016
- Kidney cancer, ESMO 2016. Journal of the Canadian Urological Association. 10:227-227. 2016
- The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 34:486.e1-486.e7. 2016
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia. Therapeutic Advances in Urology. 8:257-271. 2016
- Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes. Urology. 94:154-160. 2016
- Prostate cancer update from the American Society of Clinical Oncology (ASCO) annual meeting 2016. Canadian Urological Association Journal. 10:137-137. 2016
- Impact of resident involvement in endoscopic bladder cancer surgery on pathological outcomes. Scandinavian Journal of Urology. 50:234-238. 2016
- Update from the European Association of Urology (EAU) Annual Meeting 2016. Canadian Urological Association Journal. 10:123-123. 2016
- What’s new in prostate cancer research?. Canadian Urological Association Journal. 10:127-127. 2016
- What’s new in testosterone deficiency research?. Canadian Urological Association Journal. 10:130-130. 2016
- What’s new renal cancer research?. Canadian Urological Association Journal. 10:132-132. 2016
- Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database of Systematic Reviews. 4:CD010098. 2016
- CYB5D2 displays tumor suppression activities towards cervical cancer. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1862:556-565. 2016
- Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer. Cancer Research. 76:1603-1614. 2016
- Dataset on the effects of CYB5D2 on the distribution of HeLa cervical cancer cell cycle. Data in Brief. 6:811-816. 2016
- Evolving Strategies in the Treatment of Tuberous Sclerosis Complex-associated Angiomyolipomas (TSC-AML). Urology. 89:19-26. 2016
- Intrinsic ureteral endometriosis as a cause of unilateral obstructive uropathy. Journal of the Canadian Urological Association. 10:119-119. 2016
- Aromatase inhibitors in the treatment of oligozoospermic or azoospermic men: a systematic review of randomized controlled trials. Jornal Brasileiro de Reproducao Assistida. 20:82-88. 2016
- Emphysematous pyelonephritis in failed renal allograft:Case report and review of literature. Urology Annals. 8:111-111. 2016
- Contrast-enhanced Ultrasonography for Surveillance of Radiofrequency-ablated Renal Tumors: A Prospective, Radiologist-blinded Pilot Study. Urology. 86:1174-1178. 2015
- Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores.. Journal of Biological Chemistry. 290:28725-28725. 2015
- Clinical outcomes following laparoscopic management of pT3 renal masses: A large, multi-institutional cohort. Canadian Urological Association Journal. 9:397-397. 2015
- Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database of Systematic Reviews. 2015. 2015
- Differences between the real and the desired worlds in the results of clinical trials. Clinics. 70:618-622. 2015
- Nucleic acid amplification techniques (NAATs) for early diagnosis of HIV-1 and HIV-2 infections. Cohrane Library Clinical Respiratory Journal. 2015. 2015
- A Prospective Randomized Study of Pfannenstiel Versus Expanded Port Site Incision for Intact Specimen Extraction in Laparoscopic Radical Nephrectomy. Journal of Endourology. 29:913-918. 2015
- Oncology Brief from ASCO 2015: Update on Kidney Cancer and Prostate Cancer. Journal of the Canadian Urological Association. 9:157-157. 2015
- The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study. BJU International. 116:72-78. 2015
- Current Concepts in Genitourinary Oncology: GU-ASCO 2015. Journal of the Canadian Urological Association. 9:147-147. 2015
- Angiosarcoma of the adrenal gland with concurrent contralateral advanced renal cell carcinoma: A diagnostic and management dilemma. Journal of the Canadian Urological Association. 9:302-302. 2015
- Canadian guidelines for the management of the small renal mass (SRM). Journal of the Canadian Urological Association. 9:160-160. 2015
- Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update. Journal of the Canadian Urological Association. 9:164-164. 2015
- Renal cell carcinoma and amyopathic dermatomyositis. Journal of the Canadian Urological Association. 9:340-340. 2015
- What’s New in Prostate Cancer Research? Highlights of GU-ASCO 2015. Journal of the Canadian Urological Association. 9:148-148. 2015
- What’s New in Renal Cell Cancer Research? Highlights of GU-ASCO 2015. Journal of the Canadian Urological Association. 9:154-154. 2015
- Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma. European Urology. 67:803-812. 2015
- Surgical Management of Stage T1 Renal Tumors in Canadian Academic Centers. Journal of the Canadian Urological Association. 9:99-99. 2015
- The 2014 CUA-CUOG Guidelines for the Management of Castration Resistant Prostate Cancer (CRPC). Journal of the Canadian Urological Association. 9:90-90. 2015
- Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget. 6:1900-1919. 2015
- IQGAP2 Displays Tumor Suppression Functions. Journal of Analytical Oncology. 4:86-93. 2015
- Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities. Blood. 125:195-198. 2015
- Renal tumour scoring systems: How useful are they?. Journal of the Canadian Urological Association. 9:46-46. 2015
- Mesure de l’APS : Et maintenant… un message de nos experts. Journal of the Canadian Urological Association. 8:944-944. 2014
- PSA screening: And now…a message from our experts. Journal of the Canadian Urological Association. 8:387-387. 2014
- The impact of method of distal ureter management during radical nephroureterectomy on tumour recurrence. Journal of the Canadian Urological Association. 8:845-845. 2014
- Update on medical expulsive therapy for distal ureteral stones: Beyond alpha-blockers. Journal of the Canadian Urological Association. 8:442-442. 2014
- Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma. Oncotarget. 5:7406-7419. 2014
- Laparoscopic nephrectomy for massive polycystic kidney disease: Updated technique and outcomes. Journal of the Canadian Urological Association. 8:341-341. 2014
- Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: Results from the Canadian Upper Tract Collaboration1Co-first authors.. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 32:839-845. 2014
- Metastatic Renal Cell Carcinoma without Evidence of a Primary Renal Tumour. Current Oncology. 21:521-524. 2014
- Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: Results from a Canadian multicenter collaboration. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 32:441-448. 2014
- L'invasion robotique au Canada. Journal of the Canadian Urological Association. 8:466-466. 2014
- Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia. mBio. 5:e00884-e00814. 2014
- Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus. Journal of the Canadian Urological Association. 8:398-398. 2014
- The robotic invasion in Canada. Journal of the Canadian Urological Association. 8:151-151. 2014
- Laparoscopic Management of Advanced Renal Cell Carcinoma With Renal Vein and Inferior Vena Cava Thrombus. Urology. 83:812-817. 2014
- Update on Cryoablation for Treatment of Small Renal Mass: Oncologic Control, Renal Function Preservation, and Rate of Complications. Current Urology Reports. 15:396. 2014
- « Je vous l’avais bien dit » : Examen de l’incidence de la liste de contrôle de la sécurité chirurgicale. Journal of the Canadian Urological Association. 8:221-221. 2014
- Canadian content at GU-ASCO 2014: Highlights of research involving Canadian researchers. Canadian Urological Association Journal. 8:16-16. 2014
- New paradigms in the treatment of genitourinary malignancies: GU-ASCO Update 2014. Canadian Urological Association Journal. 8:7-7. 2014
- What’s new in prostate cancer research? Highlights of GU-ASCO 2014. Canadian Urological Association Journal. 8:8-8. 2014
- What’s new in renal cell cancer research? Highlights of GU-ASCO 2014. Canadian Urological Association Journal. 8:13-13. 2014
- “I told you so”: Examining the impact of the surgical safety checklist. Journal of the Canadian Urological Association. 8:79-79. 2014
- Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 32:31.e17-31.e24. 2014
- An alternative approach to deal with the absence of clinical trials: a proportional meta-analysis of case series studies. Acta Cirurgica Brasileira. 28:870-876. 2013
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine. 369:2093-2104. 2013
- Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin. European Journal of Cancer. 49:3537-3546. 2013
- Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration. BJU International. 112:791-797. 2013
- Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations Seminars in Urologic Oncology. 31:1161-1165. 2013
- Canadian guideline on genetic screening for hereditary renal cell cancers. Journal of the Canadian Urological Association. 7:319-319. 2013
- Canadian guidelines for postoperative surveillance of upper urinary tract urothelial carcinoma. Journal of the Canadian Urological Association. 7:306-306. 2013
- Comorbidity Status Does Not Independently Predict Survival Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. European Urology. 64:518-519. 2013
- Using the Delphi Technique to Improve Clinical Outcomes Through the Development of Quality Indicators in Renal Cell Carcinoma. Journal of Oncology Practice. 9:e262-e267. 2013
- CUA-CUOG Guidelines for the Management of Castration Resistant Prostate Cancer (CRPC): 2013 Update. Journal of the Canadian Urological Association. 7:231-231. 2013
- Dutasteride for the treatment of benign prostatic hyperplasia. Expert Opinion on Pharmacotherapy. 14:1399-1408. 2013
- Management of Renal Collecting Duct Carcinoma: A Systematic Review and the McMaster Experience. Current Oncology. 20:223-232. 2013
- Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: adjusting for the burden of ensuing chronic kidney disease. Journal of the Canadian Urological Association. 7:108-13. 2013
- The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma. World Journal of Urology. 31:175-181. 2013
- Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer. PLoS ONE. 8:e70047-e70047. 2013
- Review of the efficacy and safety of cryoablation for the treatment of small renal masses.. Journal of the Canadian Urological Association. 7:E38-E44. 2013
- Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada.. Journal of the Canadian Urological Association. 6:455-462. 2012
- Benign prostatic hyperplasia (BPH) management in the primary care setting.. Canadian Journal of Urology. 19 Suppl 1:10-17. 2012
- Laparoscopic partial nephrectomy: The McMaster University experience. Journal of the Canadian Urological Association. 6:233-237. 2012
- Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU International. 110:510-516. 2012
- Prostate cancer screening: Attitudes and practices of family physicians in Ontario. Journal of the Canadian Urological Association. 6:188-193. 2012
- IQGAP2, A candidate tumour suppressor of prostate tumorigenesis. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1822:875-884. 2012
- Transfer of Laparoscopic Radical Prostatectomy Skills From Bench Model to Animal Model: A Prospective, Single-Blind, Randomized, Controlled Study. JOURNAL OF UROLOGY. 187:1861-1866. 2012
- The Contemporary Role of Lymph Node Dissection During Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian Experience. Urology. 79:840-845. 2012
- Adenovirus-Mediated Gene Transfer of TGF-β1 to the Renal Glomeruli Leads to Proteinuria. American Journal of Pathology. 180:940-951. 2012
- Commercial renal transplantation: A risky venture? A single Canadian centre experience. Journal of the Canadian Urological Association. 5:335-340. 2011
- Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Journal of the Canadian Urological Association. 5:316-322. 2011
- Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma. Current Oncology. 18:S11-S19. 2011
- Current systemic management of metastatic renal cell carcinoma – first line and second line therapy. Current Opinion in Supportive and Palliative Care. 5:211-221. 2011
- α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells. Nature Communications. 2:307. 2011
- Guidelines for the management of the incidentally discovered adrenal mass. Journal of the Canadian Urological Association. 5:241-247. 2011
- A System for Laparoscopic Surgery Ergonomics and Skills Evaluation. Journal of Endourology. 25:1111-1114. 2011
- Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochimica et Biophysica Acta - Molecular Cell Research. 1813:683-694. 2011
- Emerging novel therapies in the treatment of castrate-resistant prostate cancer. Journal of the Canadian Urological Association. 5:120-133. 2011
- Laparoscopic pyeloplasty: the standard of care for ureteropelvic junction obstruction. Journal of the Canadian Urological Association. 5:136-138. 2011
- Life before and after residents: subjective reports on quality of life from urologists since inception of a new residency program. Journal of the Canadian Urological Association. 5:103-106. 2011
- Renal histopathology features according to various warm ischemia times in porcine laparoscopic and open surgery model. Journal of the Canadian Urological Association. 5:40-43. 2011
- Outcomes of laparoscopic donor nephrectomy in the presence of multiple renal arteries. Urology Annals. 3:62-62. 2011
- Binding of Anti-GRP78 Autoantibodies to Cell Surface GRP78 Increases Tissue Factor Procoagulant Activity via the Release of Calcium from Endoplasmic Reticulum Stores. Journal of Biological Chemistry. 285:28912-28923. 2010
- Preferred management option for small renal masses: laparoscopic partial nephrectomy. Journal of the Canadian Urological Association. 4:139-141. 2010
- Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC). Drug, Healthcare and Patient Safety. 2:85-85. 2010
- Cryoablation versus radiofrequency ablation for the treatment of small renal cell carcinoma. Cochrane Database of Systematic Reviews. 2009
- Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy. Current Opinion in Supportive and Palliative Care. 3:157-165. 2009
- Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma. Cancer. 115:3618-3630. 2009
- Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Review of Anticancer Therapy. 9:975-987. 2009
- Outcome of Third Renal Allograft Retransplants Versus Primary Transplants from Paired Donors. Transplantation. 87:1214-1220. 2009
- Laparoscopic partial nephrectomy: a challenging operation with a steep learning curve. Journal of the Canadian Urological Association. 3:119-119. 2009
- Laparoscopic right donor nephrectomy. BJU International. 103:998-1013. 2009
- Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Journal of the Canadian Urological Association. 3:143-143. 2009
- Computerized Tomography Measurement of Visceral Adiposity Predicts Plasma Adiponectin Levels and Metastatic Disease in Patients with Clear Cell Renal Cell Carcinoma. Current Urology. 2:188-193. 2009
- Task-specific bench model training versus basic laparoscopic skills training for laparoscopic radical prostatectomy: a randomized controlled study. Journal of the Canadian Urological Association. 3:22-22. 2009
- Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma. Current Oncology. 16:S62-S68. 2009
- Inhibition of mTOR in kidney cancer. Current Oncology. 16:S35-S41. 2009
- PTEN inhibits BMI1 function independently of its phosphatase activity. Molecular Cancer. 8:98-98. 2009
- Specific Reduction of Fas-Associated Protein with Death Domain (FADD) in Clear Cell Renal Cell Carcinoma. Cancer Investigation. 27:836-843. 2009
- Treatment of adult rhabdoid renal cell carcinoma with sorafenib. Journal of the Canadian Urological Association. 2:631-631. 2008
- Bmi1 promotes prostate tumorigenesis via inhibiting p16INK4A and p14ARF expression. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1782:642-648. 2008
- Lower Plasma Adiponectin Levels Are Associated with Larger Tumor Size and Metastasis in Clear-Cell Carcinoma of the Kidney. European Urology. 54:866-874. 2008
- Laparoscopic pyeloplasty: the updated McMaster University experience. Journal of the Canadian Urological Association. 2:388-388. 2008
- Laparoscopic Nephrectomy with Intact Specimen Extraction for Polycystic Kidney Disease. Journal of Endourology. 22:675-680. 2008
- Laparoscopic pyeloplasty: Role of preoperative retrograde pyelography. Journal of Pediatric Urology. 4:162-164. 2008
- Urological Oncology: Renal, Ureteral and Retroperitoneal Tumors. JOURNAL OF UROLOGY. 179:496-498. 2008
- Malignancy in Kidney Transplant Recipients. Drugs. 68:11-19. 2008
- Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1772:1134-1142. 2007
- Uncertainty in ultrasound reporting. Journal of the Canadian Urological Association. 1:255. 2007
- Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma. Journal of the Canadian Urological Association. 1. 2007
- Systemic therapy for patients with advanced, unresectable or metastatic renal cell carcinoma: Moving to guidelines. Journal of the Canadian Urological Association. 1. 2007
- Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma. New England Journal of Medicine. 356:2271-2281. 2007
- Intact Specimen Extraction in Laparoscopic Nephrectomy Procedures: Pfannenstiel Versus Expanded Port Site Incisions. Urology. 69:241-244. 2007
- Comparison of laparoscopic and open nephrectomy for adult polycystic kidney disease: operative challenges and technique.. Canadian Journal of Urology. 13:3340-3345. 2006
- ATM activation is accompanied with earlier stages of prostate tumorigenesis. Biochimica et Biophysica Acta - Molecular Cell Research. 1763:1090-1097. 2006
- Laparoscopic excision of para-aortic ectopic pheochromocytoma.. Canadian Journal of Urology. 13:3271-3274. 2006
- Laparoscopic management of advanced renal cell carcinoma with level I renal vein thrombus. Urology. 68:514-517. 2006
- Robot-assisted laparoscopic renal artery aneurysm reconstruction. Journal of Vascular Surgery. 44:651-653. 2006
- Radiation-induced genomic instability is associated with DNA methylation changes in cultured human keratinocytes. MUTATION RESEARCH. 597:87-97. 2006
- ERK activity facilitates activation of the S-phase DNA damage checkpoint by modulating ATR function. Oncogene. 25:1153-1164. 2006
- TERMINAL LOOP CUTANEOUS URETEROSTOMY IN RENAL TRANSPLANTATION: AN UNDER UTILIZED URINARY DIVERSION TECHNIQUE. JOURNAL OF UROLOGY. 174:1906-1909. 2005
- Urological manifestations of BK polyomavirus in renal transplant recipients.. Canadian Journal of Urology. 12:2829-2836. 2005
- Laparoscopic nephrectomy for emphysematous pyelonephritis.. Canadian Journal of Urology. 12:2764-2768. 2005
- Identification of a novel Wee1 isoform. Biochimica et Biophysica Acta - Gene Structure and Expression Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 1729:1-9. 2005
- Primary small cell carcinoma of the ureter.. Canadian Journal of Urology. 12:2603-2606. 2005
- ATM activity contributes to the tumor-suppressing functions of p14ARF. Oncogene. 23:7355-7365. 2004
- Comparison of Laparoscopic Radical Renal Surgery in Morbidly Obese and Non-obese Patients. Journal of Endourology. 18:657-660. 2004
- Laparoscopic versus open partial nephrectomy. Urology. 64:458-461. 2004
- McMaster experience with laparoscopic pyeloplasty.. Canadian Journal of Urology. 11:2299-2302. 2004
- Technique of laparoscopic nephrectomy in a patient with previous urinary diversion.. Canadian Journal of Urology. 10:2017-2019. 2003
- Herpes zoster infection: a rare cause of acute urinary retention.. Canadian Journal of Urology. 10:1912-1913. 2003
- Apoptotic Release of Histones from Nucleosomes. Journal of Biological Chemistry. 277:12001-12008. 2002
- Laparoscopic wedge resection of a renal mass in a solitary kidney.. Canadian Journal of Urology. 8:1297-1299. 2001
- ARTHROGRYPOSIS MULTIPLEX CONGENITA: BLOOD VESSEL HYPOPLASIA AND IMPLICATIONS DURING RENAL TRANSPLANTATION. JOURNAL OF UROLOGY. 165:174-174. 2001
- A Physical Modeling Study of Fluid-flow Phenomena in Gas-Slag.. ISIJ International. 37:829-838. 1997
-
chapter
-
conference paper
- Assessing interrater variation with funnel plots in 2,190 prostate biopsies. Virchows Archiv. S27-S27. 2017
- Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data. Annals of Oncology. 2017
- New research in bladder cancer, ASCO 2017. Journal of the Canadian Urological Association. S301-2. 2017
- New research in kidney cancer, ASCO 2017. Journal of the Canadian Urological Association. S298-300. 2017
- New research in prostate cancer, ASCO 2017. Journal of the Canadian Urological Association. S303-4. 2017
- Real world outcomes of patients with metastatic renal cell carcinoma (mRCC) using first-line sunitinib or pazopanib: the Canadian experience. Annals of Oncology. vi285-vi285. 2016
- Androgen receptor axis-targeted agents. Canadian Urological Association Journal. 146-146. 2016
- Chemotherapy research for metastatic prostate cancer. Canadian Urological Association Journal. 140-140. 2016
- HOW EFFECTIVE IS ELECTRICAL STIMULATION WITH NON-IMPLANTED DEVICES IN TREATING OVERACTIVE BLADDER? A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS. Neurourology and Urodynamics. S379-S380. 2016
- Localized prostate cancer. Canadian Urological Association Journal. 138-138. 2016
- Radionulcides. Canadian Urological Association Journal. 144-144. 2016
- Phase II study of individualized sunitinib as first-line therapy for metastatic renal cell cancer (mRCC).. Journal of Clinical Oncology. 4555-4555. 2015
- The impact of renal cell carcinoma histopathological subtype on disease prognosis: A Canadian multi-institutional analysis.. Journal of Clinical Oncology. 480-480. 2015
- The proportion and characterization of patients with metastatic renal cell carcinoma who are never treated or have delayed treatment with targeted therapy: Results from a large prospective cohort.. Journal of Clinical Oncology. 424-424. 2015
- Contemporary outcomes of pT3 renal cell carcinoma: A Canadian multi-institutional experience.. Journal of Clinical Oncology. 434-434. 2014
- Positive surgical margins after partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer Information System database.. Journal of Clinical Oncology. 420-420. 2014
- The role of FSH in castration-induced adipogenesis: Highlighting differences between orchiectomy, GNRH agonists, and antagonists.. Journal of Clinical Oncology. 2013
- Improving outcomes through the development of quality indicators in renal cell cancer.. Journal of Clinical Oncology. 422-422. 2012
- Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: A multicenter analysis of 742 patients. European Urology, Supplements. E767-U628. 2012
- Neoadjuvant temsirolimus in high-risk renal cell carcinoma: Results from a single-center prospective study.. Journal of Clinical Oncology. 387-387. 2011
- Correlation of computerized tomography measurement of visceral adiposity with plasma adiponectin levels and presence of metastatic disease in patients with clear cell renal cell carcinoma. Journal of Clinical Oncology. 5118-5118. 2008
- Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear cell carcinoma of the kidney. Journal of Clinical Oncology. 22225-22225. 2008
- Progression free survival in patients with metastatic and recurrent renal cancer treated with sorafenib—Single center experience. Journal of Clinical Oncology. 16141-16141. 2008
- Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma. Journal of the Canadian Urological Association. S28-S33. 2007
- Systemic therapy for patients with advanced, unresectable or metastatic renal cell carcinoma: moving to guidelines. Journal of the Canadian Urological Association. S34-S40. 2007
- Transforming growth factor beta 1 over expression in the rodent kidney - A non-inflammatory model of chronic allograft nephropathy.. American Journal of Transplantation. 417-417. 2007
- A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR plus IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC). Journal of Clinical Oncology. 930S-930S. 2006
- A phase III, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR plus IFN in the treatment of first-line, poor-prognosis patients with advanced renal cell carcinoma.. Journal of Clinical Oncology. 2S-2S. 2006
- A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR plus IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (ADV RCC). Annals of Oncology. 54-54. 2006